XML 65 R36.htm IDEA: XBRL DOCUMENT v3.25.1
SEGMENT INFORMATION (Tables)
 12 Months Ended
Dec. 31, 2024
Segment Reporting [Abstract]  
Schedule of segment reporting information, by segment
   
Year ended December 31
  
   
2024
    
2023
  
Clinical trials and other services from R&D-related service providers
  
$
1,893
    
$
2,480
  
Payroll and related expenses, other than share-based compensation
    
2,385
      
1,199
  
Share-based compensation expenses
    
5,862
      
130
  
Depreciation expenses
    
25
      
45
  
Other segment expenses (*)
    
2,406
      
827
  
Operating loss
    
12,571
      
4,681
  
Interest income
    
(28
)
    
(153
)

Interest expense

     27       -  
Other financing expense, net
    
3,939
      
548
  
Income taxes
    
10
      
32
  
Net loss
  
$
16,519
    
$
5,108
  
                 
Segment assets
  
$
2,863
    
$
5,256
  
Expenditures for segment assets
    
(22
)
    
(12
)
 
(*) Other segment expenses include mainly general and administrative-related expenses, such as payments to advisors and consultants, office lease expenses and maintenance, HR and legal expenses.